Zafgen Inc.

(ZFGN) Trade

By |

Profile

Zafgen Inc is a biopharmaceutical company engaged in improving the health and well-being of patients affected by obesity and complex metabolic disorders. Its product candidate include Beloranib.

Contact Information

Website: www.zafgen.com
Email: david@argotpartners.com
Main Phone: +1 617 622-4003
Address: 175 Portland Street
Address 2: 4th Floor
State: MA
City / Town: Boston
Country: USA
Postal Code: 02114

Issuer Information

Exchange: NGS
CEO: Jeffrey S. Hatfield
Employees: 35
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 10.78 $ -0.17 (-1.55%)
Last Price 10.78 Change $ -0.17 Change % -1.55 Tick N/A
Bid 9.05 Bid Size 1,000.00 Ask 11.60 Ask Size 100.00
Open 10.82 High 10.94 Low 10.28 Prev Close 10.95
Last Trade Volume 1.2 mi 52 Wk Hi 11.39 52 Wk Low 3.31
Market Cap 396.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 36,805,591.00 EPS (TTM) -2.09 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 5
Number of Buys 0 4
Number of Sells 0 1
Net Activity 0 32856
Last 10 Buys Shares
Frances K. Heller 1,000
Dennis D. Kim 1,000
Dennis D. Kim 1,000
Dennis D. Kim 1,000
Frances K. Heller 1,000
Frances K. Heller 1,000
Thomas E. Hughes 1,000
Patricia L. Allen 1,000
Patricia L. Allen 1,000
Thomas E. Hughes 1,000
Last 10 Sell Shares
Thomas E. Hughes 1,000
Flynn E James 1,000
Flynn E James 1,000
Flynn E James 1,000
Kevin P. Starr 1,000
Kevin P. Starr 1,000
Thomas E. Hughes 1,000
Avi Goldberg 1,000
Thomas E. Hughes 1,000
Alicia Secor 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 9 9 9 9
Low Target Price Estimate 9 9 9 9
Mean Target Price Estimate 9 9 9 9
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 03/07/18 03/07/18 03/07/18 03/07/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 3 3 3 3